Leerink Swann Maintains a 'Market Perform' on Allscripts (MDRX);
Tweet Send to a FriendGet Alerts MDRX Hot Sheet
Price: $14.01 -0.57%
Rating Summary:
11 Buy, 16 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Rating Summary:
11 Buy, 16 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Trade MDRX Now!
Leerink Swann maintains a 'Market Perform' on Allscripts (NASDAQ: MDRX) price target $9-10.
Analyst, David Larsen, said, "We are more cautious on shares of MDRX following a recent meeting with the CMIO of a large integrated delivery network (IDN) that uses a variety of technology systems including Allscripts' Enterprise and Sunrise platforms. Based on our conversation, which adds weight to comments we had heard from others, we believe that bookings for Allscripts may continue to deteriorate, and we suspect several hospitals may seek to jump from Sunrise to other vendors in 2012 and 2013. While shares of MDRX have pulled in significantly, we believe the stock will trade on bookings and we maintain our rating."
FY12 EPS estimate cut from $0.75 to $0.65 and FY12 from $0.85 to $0.80.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $10.90 yesterday, with a 52 week range of $8.99-$21.66.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, David Larsen, said, "We are more cautious on shares of MDRX following a recent meeting with the CMIO of a large integrated delivery network (IDN) that uses a variety of technology systems including Allscripts' Enterprise and Sunrise platforms. Based on our conversation, which adds weight to comments we had heard from others, we believe that bookings for Allscripts may continue to deteriorate, and we suspect several hospitals may seek to jump from Sunrise to other vendors in 2012 and 2013. While shares of MDRX have pulled in significantly, we believe the stock will trade on bookings and we maintain our rating."
FY12 EPS estimate cut from $0.75 to $0.65 and FY12 from $0.85 to $0.80.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $10.90 yesterday, with a 52 week range of $8.99-$21.66.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UBS Raises PT on Tesoro (TSO)
- Best Buy (BBY) May Show Progress on Earnings Front, UBS Remains Neutral
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
